NCT03859934View on ClinicalTrials.gov

Metabolic Effects of Melatonin Treatment

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

September 26, 2019

Primary Completion Date

May 3, 2021

Study Completion Date

August 18, 2021

Conditions
Metabolic DiseaseInsulin SensitivityGlucose Metabolism Disorders (Including Diabetes Mellitus)Type 2 Diabetes MellitusBlood PressureInflammation
Interventions
DRUG

Melatonin

Melatonin treatment

DRUG

Placebo Oral Tablet

Placebo treatment

Trial Locations (1)

8200

Medical Research Laboratory, Aarhus

All Listed Sponsors
collaborator

University of Copenhagen

OTHER

lead

University of Aarhus

OTHER

NCT03859934 - Metabolic Effects of Melatonin Treatment | Biotech Hunter | Biotech Hunter